跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
郭 漢彬
教授
,
胸腔內科
講座教授
,
醫學院
合聘教授
,
臨床醫學研究所
合聘教授
,
醫學院人工智慧醫療碩士在職專班
合聘教授
,
細胞治療與再生醫學國際博士學位學程
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學胸腔醫學研究中心
成員
,
臺北醫學大學細胞治療與再生醫學研究中心
https://orcid.org/0000-0003-2142-2440
電子郵件
q8828
tmu.edu
tw
h-index
9576
引文
47
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1989 …
2025
每年研究成果
概覽
指紋
網路
專案
(9)
研究成果
(246)
類似的個人檔案
(6)
指紋
查看啟用 Han-Pin Kuo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
86%
Chronic Obstructive Lung Disease
60%
Non Small Cell Lung Cancer
56%
Epidermal Growth Factor Receptor
50%
Guinea Pig
43%
Nitric Oxide
33%
Tumor Necrosis Factor
31%
Lung Tuberculosis
27%
Chemotherapy
25%
Lipopolysaccharide
21%
Airway Obstruction
19%
Lung Adenocarcinoma
19%
Placebo
18%
Interleukin 8
18%
Capsaicin
18%
Cytokine
17%
Inflammation
17%
Disease
17%
Lung Cancer
16%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%
Nuclear Factor
16%
Alternative Complement Pathway C3 C5 Convertase
16%
Gefitinib
16%
Mitogen Activated Protein Kinase
15%
Interleukin 1
15%
Emphysema
15%
Normal Human
14%
Sepsis
14%
Immunoglobulin E
14%
Symptom
14%
Neoplasm
14%
Randomized Controlled Trial
13%
Erlotinib
13%
Allergic Asthma
13%
Sleep Disordered Breathing
13%
Cigarette Smoke
13%
Cyclooxygenase 2
13%
Lipoteichoic Acid
13%
Omalizumab
13%
Budesonide
13%
Overall Survival
12%
Adverse Event
12%
Connective Tissue Growth Factor
12%
Substance P
12%
Progression Free Survival
11%
Oxidizing Agent
11%
Propofol
11%
Intercellular Adhesion Molecule 1
11%
Multiple Organ Failure
10%
Protein Kinase C
10%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
71%
Bronchoscopy
57%
Asthma
54%
Diagnosis
36%
Endobronchial Ultrasonography
36%
Non Small Cell Lung Cancer
33%
Airway Obstruction
28%
Lung Cancer
25%
Lung Tuberculosis
23%
Forced Expiratory Volume
23%
Neutrophil
22%
Lung Biopsy
20%
Continuous Positive Airway Pressure
19%
Epidermal Growth Factor Receptor
19%
Randomized Controlled Trial
18%
Self-Expandable Metallic Stent
18%
Sepsis
18%
Bronchiectasis
18%
Goblet Cell
18%
Cellular Secretion
18%
Propofol
17%
Lung Function
17%
Disease
16%
Emphysema
15%
Forced Vital Capacity
14%
Exercise
13%
Multiple Organ Dysfunction Syndrome
13%
Budesonide
13%
Placebo
13%
Lung Lavage
12%
Cancer
12%
Obstructive Sleep Apnea
12%
Trachea
12%
Odds Ratio
11%
Adverse Event
11%
Sputum
11%
Diagnostic Accuracy
11%
Disease Course
11%
Neoplasm
10%
Gefitinib
10%
Intensive Care Unit
10%
Stenting
10%
Capsaicin
10%
Particular Matter 2.5
10%
Six Minute Walk Test
10%
Cigarette Smoke
10%
Stent Fracture
10%
Symptom
10%
Hypoxemia
9%
Transbronchial Aspiration
9%
Immunology and Microbiology
Asthma
100%
Alveolar Macrophage
43%
Neutrophil
42%
Normal Human
31%
Tumor Necrosis Factor
31%
Upregulation
28%
Severe Asthma
23%
Allergic Asthma
23%
Interleukin 8
23%
Forced Expiratory Volume
22%
Eosinophil Granulocyte
20%
Eosinophil
19%
Guinea Pig
18%
Cytokine
18%
Monocyte
18%
Neutrophil Granulocyte
17%
Airflow
16%
T Cell
16%
Immunoglobulin E
16%
Peripheral Blood Mononuclear Cell
15%
Respiratory Tract Allergy
15%
Blood Plasma
15%
Interleukin 1
14%
Cytokine Release
14%
Lung Function
13%
Goblet Cell
13%
Exhaled Nitric Oxide
13%
Promoter Region
12%
CD34
11%
Agonist
11%
Pulmonary Inflammation
11%
Cellular Secretion
11%
Interleukin 5
11%
Mycobacterium Tuberculosis
11%
Sputum
11%
Oxidative Stress
11%
Interleukin 33
10%
CD18
10%
Budesonide
10%
Hydrogen Peroxide
10%
Bcl-2
10%
CD14
9%
Mitogen
9%
Chemokine
9%
B Cell
9%
Omalizumab
9%
COVID-19
9%
Airway Smooth Muscle Cell
9%
Myeloid-Derived Suppressor Cell
9%
Mucus Secretion
9%
